by SD-AbarceoPharma | Oct 4, 2018 | Diabetes, VDAC1
Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi, world-class experts in beta cell biology, discovered that hyperglycemia increases VDAC1 expression and is mistargeted to the beta cell surface in Type 2 diabetes patients. Read...
Recent Comments